Bulletin
Investor Alert

CymaBay Therapeutics Inc.

NAS: CBAY

GO
/marketstate/country/us

After Hours

/zigman2/quotes/201917619/composite

$

1.90

Change

0.00 0.00%

Volume

Volume 1,152

Jan 24, 2020, 5:20 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/201917619/composite

Previous close

$ 1.90

$ 1.90

Change

0.00 0.00%

Day low

Day high

$1.86

$1.94

Open
Open: 1.91

52 week low

52 week high

$1.29

$14.00

Open

Market cap

$130.53M

Average volume

2.60M

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-1.43

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/cbay

MarketWatch News on CBAY

  1. CymaBay Therapeutics downgraded to market perform vs. strong buy at Raymond James

    8:48 a.m. Nov. 26, 2019

    - Ciara Linnane

  2. CymaBay Therapeutics shares down 77% premarket after resuming trade following halt

    8:33 a.m. Nov. 25, 2019

    - Ciara Linnane

  3. CymaBay shares fall 77% on halted trial

    8:34 a.m. Nov. 25, 2019

    - Jaimy Lee

  4. CymaBay Therapeutics started at buy with $14 stock price target at Stifel Nicolaus

    6:45 a.m. June 25, 2019

    - Tomi Kilgore

  5. CymaBay Therapeutics stock price target cut to $7 from $11 at B. Riley FBR

    11:15 a.m. June 17, 2019

    - Tomi Kilgore

  6. CymaBay Therapeutics upgraded to strong buy from market outperform at Raymond James

    6:27 a.m. June 12, 2019

    - Tomi Kilgore

  7. CymaBay Therapeutics started at neutral with $9 stock price target at B. Riley FBR

    9:08 a.m. Feb. 6, 2019

    - Tomi Kilgore

  8. CymaBay Therapeutics reiterated as buy at SunTrust Robinson Humphrey

    7:46 a.m. Dec. 31, 2018

    - Ciara Linnane

  9. 4 charts to watch as tech stocks rebound

    11:18 a.m. Feb. 14, 2018

    - Harry Boxer

  10. CymaBay Therapeutics started at outperform with $35 stock price target at Evercore ISI

    7:40 a.m. Feb. 13, 2018

    - Tomi Kilgore

  11. Harry Boxer’s momentum stocks to watch this week

    10:12 a.m. Oct. 25, 2017

    - Harry Boxer

  12. CymaBay Therapeutics started at buy with $15 stock price target at SunTrust RH

    6:35 a.m. Aug. 18, 2017

    - Tomi Kilgore

Analyst Ratings

/news/nonmarketwatch/company/us/cbay

Other News on CBAY

  1. CymaBay Therapeutics Enters Oversold Territory

    9:21 a.m. Jan. 10, 2020

    - Zacks.com

  2. These Falling Knives May Be Worth Catching

    10:48 a.m. Dec. 31, 2019

    - GuruFocus.com

  3. X, MITO among premarket losers

    9:12 a.m. Dec. 20, 2019

    - Seeking Alpha

  4. CymaBay to cut 60% of workforce; shares down 8% after hours

    10:13 p.m. Dec. 19, 2019

    - Seeking Alpha

  5. Gilead (GILD) Announces Top-Line Results From NASH Study

    10:31 a.m. Dec. 17, 2019

    - Zacks.com

  6. Genfit Hopes to Buck the Odds With NASH Drug

    2:36 p.m. Dec. 10, 2019

    - GuruFocus.com

  7. NASH Scorecard Year to Date: The Winners and the Losers

    8:41 a.m. Nov. 29, 2019

    - Zacks.com

  8. Company News For Nov 26, 2019

    11:07 a.m. Nov. 26, 2019

    - Zacks.com

  9. Intercept's (ICPT) NDA for NASH Drug Gets Priority Review

    8:24 a.m. Nov. 26, 2019

    - Zacks.com

  10. ARWR, KL, ADMP and SRNE among midday movers

    12:41 p.m. Nov. 25, 2019

    - Seeking Alpha

  11. CymaBay Therapeutics (CBAY) Investor Presentation - Slideshow

    2:55 p.m. Nov. 8, 2019

    - Seeking Alpha

  12. CymaBay presenting two abstracts at Liver Meeting

    3:52 p.m. Oct. 1, 2019

    - Seeking Alpha

  13. 7 Stocks the Insiders Are Buying on Sale

    1:13 p.m. Oct. 1, 2019

    - InvestorPlace.com

  14. Genfit And GenKyoTex In PBC: What To Expect In Phase 3

    4:18 p.m. Aug. 20, 2019

    - Seeking Alpha

  15. CymaBay And Seladelpar In PSC: The Imminent Phase 2 Study

    5:16 p.m. Aug. 16, 2019

    - Seeking Alpha

  16. Loading more headlines...
/news/pressrelease/company/us/cbay

Press Releases on CBAY

  1. Hypertriglyceridemia Treatment Market Drugs to Improve longer term effects

    11:36 a.m. Jan. 22, 2020

    - HTF Market Intelligence

  2. 5 Penny Stocks To Watch Before Black Friday 2019

    8:42 a.m. Dec. 4, 2019

    - Penny Stocks

  3. Hypercholesterolemia Treatment Market Size, Status and Forecast 2019-2025

    11:05 p.m. Dec. 2, 2019

    - Market Insight Reports

  4. CymaBay Therapeutics Halts Clinical Development of Seladelpar

    8:01 a.m. Nov. 25, 2019

    - GlobeNewswire

  5. CymaBay Therapeutics Halts Clinical Development of Seladelpar

    8:00 a.m. Nov. 25, 2019

    - GlobeNewswire

  6. Loading more headlines...

Rates »

Link to MarketWatch's Slice.